Results 31 to 40 of about 21,677 (267)

Glycopyrrolate/formoterol fumarate metered dose inhaler for maintenance-naïve patients with chronic obstructive pulmonary disease:a post-hoc analysis of the randomized PINNACLE trials [PDF]

, 2020
Background: Glycopyrrolate (GP)/formoterol fumarate (FF; GFF) metered dose inhaler is a fixed-dose combination dual bronchodilator for patients with chronic obstructive pulmonary disease (COPD); however, whether the efficacy in patients without current ...
A Anzueto, AD D'Urzo, B Alcázar Navarrete, BJ Lipworth, BR Celli, C Tantucci, C Vogelmeier, D Price, D Singh, FJ Martinez, FJ Martinez, GJ Rodrigo, Global Initiative for Chronic Obstructive Lung Disease (GOLD), GT Ferguson, I Naya, J Vestbo, JF Donohue, L Calzetta, L Calzetta, LH Bjermer, M Barrecheguren, M Cazzola, M Decramer, M Decramer, MR Maleki-Yazdi, MT Dransfield, P Rogliani, PO Bridevaux, R Buhl, T Troosters, WP Battisti, Y Oba, YS Punekar   +32 more
core   +2 more sources

Cost-utility of as-needed ICS-formoterol versus to maintenance ICS in mild to moderate persistent asthma

BMC Pulmonary Medicine, 2021
Background Recent asthma guidelines, such as the Global Initiative for Asthma (GINA), recommend in adult patients as-needed inhaled corticosteroids (ICS)-formoterol as an alternative to maintenance ICS in mild to moderate persistent asthma.
Jefferson Antonio Buendía, Diana Guerrero Patiño   +1 more
doaj   +1 more source

Brand and generic use of inhalation medication and frequency of switching in children and adults : a population-based cohort study [PDF]

, 2018
BACKGROUND: The expiration of patents of brand inhalation medications and the ongoing pressure on healthcare budgets resulted in a growing market for generics.
de Jongste, Johan C, Engelkes, Marjolein, Herings, Ron CM, Janssens, Hettie M, Kuiper, Josephine, Overbeek, Jetty A, Sturkenboom, Miriam CJM, van Blijderveen, Jan C, Verhamme, Katia   +8 more
core   +1 more source

Fluticasone/formoterol combination therapy is as effective as fluticasone/salmeterol in the treatment of asthma, but has a more rapid onset of action: an open-label, randomized study

BMC Pulmonary Medicine, 2011
Background The inhaled corticosteroid (ICS) fluticasone propionate (fluticasone) and the long-acting β2-agonist (LABA) formoterol fumarate (formoterol) are being made available as a combination product (fluticasone/formoterol, flutiform®) in a single ...
McAulay Kirsten, Dymek Andrzej, Bodzenta-Lukaszyk Anna, Mansikka Heikki   +3 more
doaj   +1 more source

Regular treatment with formoterol and inhaled steroids for chronic asthma: serious adverse events (Review) [PDF]

, 2009
Background Epidemiological evidence has suggested a link between beta2-agonists and increases in asthma mortality. There has been much debate about possible causal links for this association, and whether regular (daily) long-acting beta2-agonists are ...
Cates, CJ, Jaeschke, R, Lasserson, TJ
core   +1 more source

Effect of beta2-adrenergic agonists on eosinophil adhesion, superoxide anion generation, and degranulation

Allergology International, 2015
Background: Eosinophils play important roles in the development of asthma exacerbation. Viral infection is a major cause of asthma exacerbation, and the expression of IFN-γ-inducible protein of 10 kDa (IP-10) and cysteinyl leukotrienes (cysLTs) is up ...
Toru Noguchi, Kazuyuki Nakagome, Takehito Kobayashi, Yutaka Ueda, Tomoyuki Soma, Hidetomo Nakamoto, Makoto Nagata   +6 more
doaj   +1 more source

Fixed-dose combination fluticasone/formoterol for asthma treatment in a real-world setting: meta-analysis of exacerbation rates and asthma control

European Clinical Respiratory Journal, 2023
Background: Treatment guidelines for asthma management are derived almost exclusively from the results of controlled clinical trials undertaken in carefully selected patient populations; meaning that their outcomes may not reflect the true performance of
Alberto Papi, Murtaza Qasuri, Ernestine Chung, Mohamed Abdelbaset, Mohamed Aly Moussa, Vibeke Backer, Olaf Schmidt, Omar Usmani   +7 more
doaj   +1 more source

Combination formoterol and budesonide as maintenance and reliever therapy versus inhaled steroid maintenance for chronic asthma in adults and children (Review) [PDF]

, 2009
Background Traditionally inhaled treatment for asthma has been considered as preventer and reliever therapy. The combination of formoterol and budesonide in a single inhaler introduces the possibility of using a single inhaler for both prevention and ...
Adams, Balanzat, Bateman, Berggren, Bisgaard, Bisgaard, Bleecker, Bousquet, Bruce, Buhl, Buhl, Cates, Cates Christopher, D'Urzo, Greenstone, Haahtela, Haahtela, Higgins, Higgins, Ind, Jenkins, Johansson, Jonkers, Kuna, Kuna, Lasserson, Loukides, Lundborg, Ni Chroinin, O'Byrne, O'Byrne, O'Byrne, O'Byrne, O'Byrne, O'Byrne, Palmqvist, Price, Price, Rabe, Rabe, Rabe, Richter, Scicchitano, Sears, Sovani, Tattersfield, Tattersfield, Vogelmeier, Vogelmeier, Vogelmeier, Walters   +50 more
core   +1 more source

Long-acting beta2-agonists for chronic obstructive pulmonary disease. [PDF]

, 2013
BACKGROUND: Chronic obstructive pulmonary disease (COPD) is a respiratory disease that causes progressive symptoms of breathlessness, cough and mucus build-up.
Aalbers, Allegra, Amgott, Anderson, Appleton, Arievich, Bateman, Bateman, Baumgartner, Beeh, Berger, Bleecker, Bleecker, Bogdan, Bogdan, Boyd, Boyd, Briggs, British Medical Association and the Royal Pharmaceutical Society of Great Britain, Brusasco, Brusasco, Calverley, Calverley, Calverley, Calverley, Calverley, Calverley, Calverley, Calverley, Calverley, Calverley, Calverley, Calverley, Calverley, Calverley, Calverley, Calverley, Calverley, Calverley, Calverley, Calverley, Campbell, Campbell, Celli, Celli, Celli, Celli, Celli, Celli, Celli, Celli, Chapman, Chapman, Cheyne, Chong, Chong, Corhay, Dahl, Dahl, Dahl, Dahl, Dahl, Dahl, Dal Negro, Dal Negro, Doherty, Doherty, Doherty, Doherty, Donohue, Donohue, Donohue, Donohue, Effing, Ferguson, Ferguson, Ferguson, Ferguson, Ferguson, Ferguson, Ferguson, Ferguson, Ferguson, Ferguson, Ferguson, Ferguson, Ferguson, Geake, Greefhorst, Greefhorst, Greefhorst, Gross, Hanania, Hanania, Hanrahan, Hanrahan, Hanrahan, Hanrahan, Hanrahan, Higgins, Hogan, Horstman, Hunjan, Hunjan, Hutchinson, Jenkins, Jenkins, Jones, Jones, Jones, Jones, Jones, Jones, Jones, Jones, Karner, Karner, Karner, Karner, Karner, Keene, Kerwin, Kerwin, Khamis, Kliber, Kornmann, Kornmann, Kristufek, Kristufek, Kristufek, Lacasse, Laties, Littner, Lofdahl, Lofdahl, Lofdahl, Lofdahl, Mahler, Mahler, Mahler, Mahler, Matiz-Bueno, Matiz-Bueno, McDonough, McGarvey, Meer, Nannini, Nannini, Nannini, Nelson, Nelson, Nelson, Nelson, Nitschmann, Noord, Noord, Puhan, Qaseem, Rennard, Rennard, Rennard, Rennard, Rodrigo, Rossi, Rutten-van Molken, Rutten-van Mölken, Sacchetta, Sciurba, Song, Spencer, Spencer, Spencer, Spencer, Spencer, Spencer, Stahl, Steffensen, Steffensen, Stockley, Stockley, Szafranski, Tashkin, Tashkin, Tashkin, Tashkin, Tashkin, Tashkin, Tashkin, Vestbo, Vestbo, Vestbo, Vestbo, Vogelmeier, Vogelmeier, Wadbo, Wang, Watkins, Welsh, Yang   +198 more
core   +1 more source

Risk of active tuberculosis among COPD patients treated with fixed combinations of long-acting beta2 agonists and inhaled corticosteroids

BMC Infectious Diseases, 2020
Objectives To investigate the incidence of active tuberculosis (TB) among COPD patients using fluticasone/salmeterol or budesonide/formoterol, and to identify any differences between these two groups of patients.
Tsan-Ming Huang, Kuan-Chih Kuo, Ya-Hui Wang, Cheng-Yi Wang, Chih-Cheng Lai, Hao-Chien Wang, Likwang Chen, Chong-Jen Yu, On the behalf of Taiwan Clinical Trial Consortium for Respiratory Diseases (TCORE)   +8 more
doaj   +1 more source